Yaniv Almog

Yaniv Almog

Auto-generated profile, based on publicly available information

Yaniv Almog

Medical Intensive Care Unit and the Department of Medicine, Soroka University Medical Center, Ben Gurion University of the Negev, Beer-Sheva, Israel

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2005 in Critical Care
Verified
Journal Article
Open access
PDF file
DKDaniel A King
Daniel A King
SCShlomi Codish
Shlomi Codish
VNVictor Novack
Victor Novack
LBLeonid Barski
Leonid Barski
YAYaniv Almog
Yaniv Almog
Introduction: Myocardial injury is frequently unrecognized in intensive care unit (ICU) patients. Cardiac troponin I (cTnI), a surrogate of myocardial injury, has been shown to correlate with outcome in selected groups of patients. We wanted to determine if cTnI level measured upon admission is an independent predictor of mortality in a heterogeneous group of critically ill medical patients. Methods: We conducted a prospective observational cohort study; 128 consecutive patients admitted to a medical ICU at a tertiary university hospital were enrolled. cTnI levels were measured within 6 h of admission and were considered positive (>0.7 ng/ml) or negative. A variety of clinical and laboratory variables were recorded. Results: Both cTnI positive and negative groups were similar in terms of age, sex and pre-admission co-morbidity. In a univariate analysis, positive cTnI was associated with increased mortality (OR 7.0, 95% CI 2.44–20.5, p < 0.001), higher Acute Physiology and Chronic Health Evaluation (APACHE) II scores and a higher rate of multi-organ failure and sepsis. This association between cTnI and mortality was more pronounced among elderly patients (>65 years of age). Multivariate analysis controlling for APACHE II score revealed that elevated cTnI levels are not independently associated with 28-day mortality. Conclusion: In critically ill medical patients, elevated cTnI level measured upon admission is associated with increased mortality rate. cTnI does not independently contribute to the prediction of 28-day mortality beyond that provided by APACHE II.

1 January 2006 in Critical Care
Verified
Journal Article
Open access
PDF file
VNVictor Novack
Victor Novack
MTMarius Terblanche
Marius Terblanche
YAYaniv Almog
Yaniv Almog
Statins have a variety of properties that are independent of their lipid lowering ability. These anti-inflammatory, antioxidant, immunomodulatory, and antiapoptotic features have been collectively referred to as pleiotropic effects. Severe sepsis is an intense infection-induced inflammatory syndrome that ultimately results in organ dysfunction. Because so many cascades are triggered during sepsis, merely blocking a single component may be insufficient to arrest the inflammatory process. A growing body of evidence suggests that statins may indeed have a protective effect against severe sepsis and reduce the rate of infection-related mortality. This novel primary prevention concept may have far-reaching implications for the future management of serious infections. Moreover, it was recently shown that statins potentially improve outcome after the onset of sepsis. The stage is now set for randomized clinical trials that will determine the precise role, if any, that statins may have in preventing and treating sepsis.

1 June 2006 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
YAYaniv Almog
Yaniv Almog
VNVictor Novack
Victor Novack
RMRinat Megralishvili
Rinat Megralishvili
SKSergio Kobal
Sergio Kobal
LBLeonid Barski
Leonid Barski
DZDoron Zahger
Doron Zahger
Erum NT-pro BNP and cardiac troponin T were measured at admission, and echocardiography was performed within 24 h. The primary end-point was 30-day mortality. The median NT-pro BNP levels of the 22 (28.2%) patients who died were significantly more frequent than that of those who survived (8328 versus 1016 pg/mL; P = 0.001). Patients with NT-pro BNP levels more than 1900 pg/mL had significantly more frequent mortality (47.2% versus 11.9%; P = 0.03). This group also had more frequent moderate to severe left ventricular dysfunction (30.6% versus 9.5%; P = 0.02) and abnormal cardiac troponin T levels (33.3% versus 14.3%; P = 0.05). Multivariate analyses adjusted for APACHE-II revealed that a NT-pro BNP level more than 1900 pg/mL is an independent predictor of mortality....

1 May 2012
Verified
Journal Article
Closed access
LBLeonid Barski
Leonid Barski
RNRoman Nevzorov
Roman Nevzorov
ERElena Rabaev
Elena Rabaev
AJAlan Bruce Jotkowitz
Alan Bruce Jotkowitz
IHIlana Harman-Boehm
Ilana Harman-Boehm
YAYaniv Almog
Yaniv Almog

1 January 2009 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
LALone S. Avnon
Lone S. Avnon
OPOleg Pikovsky
Oleg Pikovsky
NSNeta Sion-Vardy
Neta Sion-Vardy
YAYaniv Almog
Yaniv Almog
Ents with hypoxemic respiratory failure who met predefined criteria of acute idiopathic interstitial pneumonia. Patients’ records, radiologic studies, and pathologic specimens were reviewed. All data were recorded in each patient’s study file and subsequently analyzed. RESULTS: Our cohort consisted of 5 men and 4 women with a mean age of 69.4 yr (55–80 yr). The chest radiograph in all patients progressed to diffuse bilateral infiltrates over a 12-day course. All nine patients had histological proof of diffuse alveolar damage consistent with acute interstitial pneumonia, obtained by either transbronchial biopsy or open lung biopsy. All patients required admission to the medical intensive care unit and mechanical ventilation. The mortality rate was 100%, and patients died within 5–26 days of their admission to the unit. CONCLUSIONS: Acute interstitial pneumonia (Hamman-Rich syndrome) is an idiopathic, rapidly progressive and, at times, fatal form of interstitial lung disease. A transbronchial biopsy is a logical first diagnostic step, to be followed by an open lung biopsy, if necessary. Response to corticosteroids in our series was minimal. In patients who fail to respond to conventional therapy and are otherwise appropriate candidates, lung transplantation may be considered as an additional alternative....

17 March 2009 in BMJ Case Reports
Verified
Journal Article
Closed access
RZReut Zaguri
Reut Zaguri
ISIlan Shelef
Ilan Shelef
GIGal Ifergan
Gal Ifergan
YAYaniv Almog
Yaniv Almog
We present the case of a young man with recent cytomegalovirus (CMV) infection who was admitted with generalised seizure and coma. Computed tomography scan and magnetic resonance imaging (MRI) on admission were normal. Despite transient initial improvement he rapidly deteriorated leading to repeated MRI that revealed findings highly suggestive of acute haemorrhagic leucoencephalitis (AHLE). The patient died despite treatment with pulse methylprednisolone and intravenous immunoglobulin. Acute disseminated encephalomyelitis (ADEM)/AHLE should be considered in the differential diagnosis of rapid neurological deterioration even when initial imaging is normal. This case report underscores the importance of early diagnosis as early aggressive treatment may improve outcome.